Literature DB >> 2026443

IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages.

P H Hart1, R L Cooper, J J Finlay-Jones.   

Abstract

Human interleukin-4 (IL-4) down-regulates IL-1 and tumour necrosis factor-alpha (TNF-alpha) production by monocytes stimulated in vitro. In contrast, in studies of activation of murine macrophages, both stimulatory and inhibitory functions of murine IL-4 have been documented. To investigate whether opposing activities of IL-4 reflect a difference in the target cell studied, due either to cell maturation or the site from which the cells were isolated, we examined the effect of IL-4 on human peritoneal macrophage production of IL-1 beta, TNF-alpha and prostaglandin E2 (PGE2). Human peritoneal macrophages stimulated with lipopolysaccharide (LPS) produced levels of these mediators that were at least as great as those previously reported for monocytes. Similarly, IL-4 was inhibitory for peritoneal macrophage mediator production after in vitro stimulation. Thus, IL-4 has effects on human peritoneal macrophages similar to those on blood monocytes. In addition, as it down-regulates mediator production by cells that have left the circulation, it may be important in controlling the immune response in tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026443      PMCID: PMC1384393     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay.

Authors:  M D Wewers; D J Herzyk
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

2.  Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.

Authors:  A A te Velde; J P Klomp; B A Yard; J E de Vries; C G Figdor
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

3.  Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.

Authors:  S J Davies; J Suassuna; C S Ogg; J S Cameron
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

4.  Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.

Authors:  P H Hart; G A Whitty; D S Piccoli; J A Hamilton
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

5.  Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-gamma.

Authors:  B H Littman; F F Dastvan; P L Carlson; K M Sanders
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

6.  Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1).

Authors:  P M Stuart; A Zlotnik; J G Woodward
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

7.  Effects of IL-4 on macrophage functions: increased uptake and killing of a protozoan parasite (Trypanosoma cruzi).

Authors:  J J Wirth; F Kierszenbaum; A Zlotnik
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

8.  Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells.

Authors:  J J Mulé; C A Smith; S A Rosenberg
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

9.  Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

Authors:  M B Widmer; R B Acres; H M Sassenfeld; K H Grabstein
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  23 in total

1.  Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.

Authors:  E Sugiyama; H Taki; A Kuroda; T Mino; N Yamashita; M Kobayashi
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

2.  Preconditioned or IL4-Secreting Mesenchymal Stem Cells Enhanced Osteogenesis at Different Stages.

Authors:  Tzuhua Lin; Yusuke Kohno; Jhih-Fong Huang; Monica Romero-Lopez; Masahiro Maruyama; Masaya Ueno; Jukka Pajarinen; Karthik Nathan; Zhenyu Yao; Fan Yang; Joy Y Wu; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2019-03-27       Impact factor: 3.845

3.  Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages.

Authors:  Prea Thathiah; Shilpa Sanapala; Annette R Rodriguez; Jieh-Juen Yu; Ashlesh K Murthy; M Neal Guentzel; Thomas G Forsthuber; James P Chambers; Bernard P Arulanandam
Journal:  Cytokine       Date:  2011-05-12       Impact factor: 3.861

4.  Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo.

Authors:  Julie M Nauroth; Ying Chun Liu; Mary Van Elswyk; Rebecca Bell; Eileen Bailey Hall; Gloria Chung; Linda M Arterburn
Journal:  Lipids       Date:  2010-04-04       Impact factor: 1.880

5.  Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.

Authors:  Athanasios Stratis; Manolis Pasparakis; Rudolf A Rupec; Doreen Markur; Karin Hartmann; Karin Scharffetter-Kochanek; Thorsten Peters; Nico van Rooijen; Thomas Krieg; Ingo Haase
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

6.  γδ T cells protect against LPS-induced lung injury.

Authors:  Fabian Wehrmann; James C Lavelle; Colm B Collins; Alex N Tinega; Joshua M Thurman; Ellen L Burnham; Philip L Simonian
Journal:  J Leukoc Biol       Date:  2015-10-01       Impact factor: 4.962

7.  Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation.

Authors:  K Suk; S D Somers; K L Erickson
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

8.  IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Authors:  P P C Souza; A B Brechter; R I Reis; C A S Costa; P Lundberg; U H Lerner
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production.

Authors:  P H Hart; C A Jones; J J Finlay-Jones
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

10.  Interleukin (IL)-4 induces leukocyte infiltration in vivo by an indirect mechanism.

Authors:  Claude Ratthé; Jamila Ennaciri; David M Garcês Gonçalves; Sonia Chiasson; Denis Girard
Journal:  Mediators Inflamm       Date:  2009-09-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.